Leuprolide Acetate Injection

Product Description

Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofLeuprolide Acetate Injectionfrom Surat, Gujarat, India. Leuprolide Acetate Injection used to treat prostate cancer, breast cancer, endometriosis,uterine fibroids, and early puberty, or as part of transgender hormone therapy.

Tags: Leuprolide Acetate Injection manufacturer, Leuprolide Acetate Injectionexporter, Leuprolide Acetate Injection supplier, and Leuprolide AcetateInjection, whogmp approved Leuprolide Acetate Injection manufacturer andsupplier, Leuprolide Acetate Injection distributor, Leuprolide Acetate Injectionshipper, Leuprolide Acetate Injection 3.75 mgLeuprolide Acetate Injection 3.75 mg supplier, Leuprolide Acetate Injection3.75 mg.

ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.

Registration: Saintroy Lifescience is interested inregistration of own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.

Export Country :Saintroy Lifescience Leuprolide Acetate Injectionexport to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.